Advanced Solid Tumor Clinical Trials in Sacramento, California

5 studies are recruiting for advanced solid tumor in Sacramento, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. SW-682 in Advanced Solid Tumors

    This is a first-in-human (FIH), Phase 1a/1b open-label, multicenter, dose escalation and dose expansion study of SW-682 in adult participants with metastatic or unresectable advanced solid tumors with or without Hippo pathway alterations that are refractory to, or have progressed, during or after a…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    UC San Diego Moores Cancer Center, Sacramento, California
    Locations
    8 in total
    Run by
    SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany

    See if you can join NCT06251310 on ClinicalTrials.gov

  2. Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

    This is a Phase I/II open label study of intravenous (IV) infusion of ONC-841 as a single agent or in combination in patients with advanced/metastatic solid tumors. The study will evaluate seven dose levels of ONC-841. The Phase 1 part is dose escalation with 7 dose levels of ONC-841 and the dose e…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of California at Davis Cancer Center, Sacramento, California
    Locations
    8 in total
    Run by
    OncoC4, Inc.

    See if you can join NCT06352359 on ClinicalTrials.gov

  3. XTX301 in Patients With Advanced Solid Tumors

    This is a first-in-human, multicenter, Phase 1/2, open-label study designed to evaluate the safety and tolerability of XTX301 as monotherapy in patients with advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of California, Davis Comprehensive Cancer Center, Sacramento, California
    Locations
    12 in total
    Run by
    Xilio Development, Inc.

    See if you can join NCT05684965 on ClinicalTrials.gov

  4. A Study of DB-1310 in Advanced/Metastatic Solid Tumors

    This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1310 in subjects with advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of California, Davis Comprehensive Cancer Center, Sacramento, California
    Locations
    24 in total
    Run by
    DualityBio Inc.

    See if you can join NCT05785741 on ClinicalTrials.gov

  5. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    Phase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p53 R175H mutation.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of California Davis Comprehensive Cancer Center, Sacramento, California
    Locations
    21 in total
    Run by
    Clasp Therapeutics, Inc.

    See if you can join NCT06778863 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.